Login / Signup
Open-label pilot study of tofacitinib 2% for the treatment of refractory vitiligo.
Pezhman Mobasher
R Guerra
S J Li
J Frangos
A K Ganesan
V Huang
Published in:
The British journal of dermatology (2019)
Keyphrases
</>
open label
rheumatoid arthritis
clinical trial
randomized controlled trial
phase ii
study protocol
phase ii study
ulcerative colitis
radiation therapy
smoking cessation
rectal cancer
replacement therapy